INTRODUCTION 14 15
Normal thyroid function is essential for development, growth, and metabolic 16 homeostasis. Permanent congenital hypothyroidism affects about 1:3000-4000 newborns, 17 and is one of the most common preventable causes of mental retardation. In about 90% of 18 all cases, congenital hypothyroidism is the consequence of thyroid dysgenesis such as a 19 small and sublingual thyroid, or no thyroid tissue. Most of these cases appear sporadically, 20 although a few cases of recurring familial thyroid dysgenesis have been described (1). 21
Molecular genetic analyses have identified four thyroid dysgenesis susceptibility genes in 22 humans, TSHR (2) and the genes for transcription factors TTF1 (3, 4), TTF2 (5) and PAX8 23 (6) in pathways crucial for the normal development of the thyroid. Studies of the 24 spontaneous mutation and targeted-disruption of Tshr (7), Ttf1 (8), Ttf2 (9), and Pax8 (10) 25 in mice have provided insight into the molecular mechanisms of organogenesis and 26 Sasaki N et al. 3/27 thereby form the basis for molecular genetic studies in human patients affected by thyroid 1 dysgenesis. However, mutations in these genes are found in only 5% of patients with 2 thyroid dysgenesis. Therefore, the genetic and pathological mechanisms underlying 3 thyroid dysgenesis are still poorly understood. 4
The growth-retarded (grt) mouse is a spontaneous mutant exhibiting severe 5 primary hypothyroidism and dwarfism controlled by a single recessive locus. The gene 6 responsible for the grt has not yet been cloned, nor has its molecular mode of action been 7 determined. However, homozygous grt mice exhibit low concentrations of serum T3 and 8 T4, and a compensatory elevation in the level of circulating TSH demonstrates a normal 9 pituitary response (11). In fact, measurements of several additional pituitary hormones 10 revealed no significant differences between normal and grt mice. Growth retardation is 11 recovered by the administration of T3, indicating that the grt mutation does not affect 12 anterior pituitary function (12). The thyroid gland of grt mice is defective in TSH 13 responsiveness, particularly in signaling pathway involving TSH, TSHR, G protein, and 14 adenylate cyclase (13). These results suggest that the growth-retarded phenotype is due to 15 an impairment of thyroid glands in the production of thyroid hormone or a response to 16 TSH. To determine the molecular mechanism of the grt phenotype, we mapped the grt 17 locus responsible for dwarfism in a 59-centimorgan (cM) region of mouse chromosome 5 18 (14) . No genes responsible for human and rodent dwarfism or thyroid disease have been 19 mapped to this region. In this report, we narrowed the grt locus to a < 0.1 cM region using 20 1,084 backcross progenies, sequenced candidate genes located in this region, and finally 21 identified a causative mutation in the tyrosylprotein sulfotransferase 2 (Tpst2) gene. 22
Recent papers reported that the posttranslational modification by tyrosine sulfation 23 regulates many important protein-protein interactions and modulates binding affinity and 24
specificity. Mutational analysis has demonstrated that TSHR is sulfated on tyrosines in a 25 motif that is essential for high-affinity binding of TSH and activation of the receptor (15). 26 Sasaki N et al. 4/27 In this report, we propose that severe thyroid hypogenesis and consequent dwarfism are 1 due to an impairment of tyrosine sulfation in TSHR by TPST2. 2 3
RESULTS

5
Identification of Tpst2 mutation in grt mutants 6 7 To identify the gene underlying the grt mutant phenotype, we created a 8 high-resolution genetic map of the grt locus using 1,084 backcross mice, and analyzed 9 their phenotypes of homozygotes (grt/grt) or heterozygotes (grt/+) by weighing mice at 5 10 wk of age. Homozygotes of both sexes were small with shortened limbs and tails and 11 weighed approximately 40-60% less of the heterozygotes or wild-type (WT) mice. None 12 of the phenotypes of 1,084 backcross progenies had recombination with a microsatellite 13 marker, D5Mit24, indicating a linkage of < 0.1 cM (Fig. 1A) . As shown in Fig. 1B , the 14 gene order was from Cryba4 to Asphd2 covering the critical region. In this region, the 15 mouse genome database disclosed seven genes, Cryba4, Crybb1, Tpst2, Tfip11, Srr1, 16 Hps4 and Asphd2. We examined the expression of these possible candidate genes in 17 multiple tissues including thyroid with RT-PCR; there was no qualitative difference 18 observed (data not shown). We next compared the nucleotide sequences of these genes 19 between normal and affected mice, and identified a distinct mutation in Tpst2. The 20 mutation is a single missense mutation with a transversion of C at nucleotide 798 to G, 21 leading to the replacement of a highly conserved histidine with a glutamine at codon 266 22 in the sulfotransferase domain (Fig. 1B) . Sequence alignment of TPST1 and 2 reveals that 23 the histidine residue was highly conserved among TPST family proteins of diverse 24 species ( Fig. 2A) . In addtion, phenotypically affected mice were homozygous for mutant 25 alleles with PCR-restriction fragment length polymorphism (RFLP) genotyping assay, 26
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whereas normal mice were homozygous for wild type alleles or heterozygous in DW/J 1 mouse colony (Fig. 2B) . Furthermore, this mutation was not present in ten other 2 laboratory strains (data not shown). These results suggested that the Tpst2 mutation is 3 responsible for the dwarfism. 4 5 Expression of Tpst2 transgene rescues the mutant phenotype 6 7
To confirm this hypothesis, we attempted to complement the grt phenotype 8 using transgenic rescue. We produced transgenic mice carrying Tpst2 cDNA driven by 9 the cytomegalovirus enhancer and chicken actin (CAG) promoter (Fig. 3A) . Founder 10 mice expressed the Tpst2 gene in several tissues including thyroid (Fig. 3B) . Crosses 11 between grt/+ males with the transgene and grt/+ females generated 17 phenotypically 12 affected mice, all of which were negative for the transgene. Twenty normal mice were 13 homozygous for the grt mutation, and all were positive for the transgene, demonstrating 14 phenotypic rescue of the dwarfism ( Fig. 3C and D) . Tpst2 overexpression had no 15 influence on growth except in grt/grt mice. Two independent founder lines produced 16 similar results. Next, we investigated the rescue of thyroid function, serum T3, T4, and 17 TSH levels were analyzed in grt/grt mice with or without transgenes. In grt/grt mice, 18 serum levels of TSH were elevated 3 to 5-fold above normal, whereas T3 and T4 levels 19 were less than normal. Rescued mutants demonstrated normal serum levels for T3, T4, 20 and TSH (Fig. 3E) . Histologically, the mutant thyroid glands showed hypogenesis 21 characterized by poorly developed follicles that were heterogeneous in size with reduced 22 levels of colloid (Fig. 4A middle, some follicles were unreactive with periodic acid schiff 23 (PAS) staining. Interestingly, the thyroids of rescued mutants revealed no abnormalities in 24 thyroid size, follicular structure, or the morphology of cells (Fig. 4A, bottom) . The 25 numbers of cells and follicles per square millimeter were in the normal range, and follicle 26
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size was not significantly different from that of normal mice (data not shown). 1 Next, to assess thyroid-specific gene expression in grt/grt mice, we performed 2 a semiquantitive RT-PCR analysis. TSH-TSHR signaling is essential for the proliferation 3 and maintenance of the differentiated function of the thyroid follicular cells, but it is not 4 required for early organogenesis and migration of the thyroid anlage (16). TSH-TSHR 5 signaling is essential for the expression of sodium-iodide symporter (Nis), 6 thyroperoxidase (Tpo) and Tshr itself, which are required for thyroid hormone 7 biosynthesis, whereas it is not required for thyroglobulin (Tgn) expression (17). These 8 observations are consistent with our results that the expression of Tshr and Nis is reduced 9 by 3-5-fold, although Tgn was normally expressed in grt/grt thyroids compared with 10 normal controls (Fig. 4B) . Previously we have shown that much less iodine is 11 accumulated in the grt/grt thyroid than in the control mice, although the incorporation of 12 iodine into thyroglobulin, glycosylation, and the intracellular transportation of 13 thyroglobulin are all normal (18). The reduction in the amount of iodine accumulated in 14 the grt/grt thyroid might be the major cause of the decrease in levels of thyroid hormones. 15
Consistent with the results of histopathology and serum hormone levels, the restoration of 16
Tpst2 rescued the levels of expression of Tshr and Nis in the transgenic mutant's thyroids 17 (Fig. 4B) . Thus, on the basis of chromosomal mapping, nucleotide sequence analysis, and 18 genetic complementation study, we concluded that the dwarf-causing grt mutation was 19 contained in the Tpst2 gene. 20
21
Loss of enzymatic activity of TPST2 H266Q mutation 22
23
TPST catalyzes the transfer of a sulfuryl group from the universal sulfation 24 substrate, 3'-phosphoadenosine 5'-phosphosulfate (PAPS), to a tyrosyl residue within 25 acidic motifs of proteins that transit the Golgi (Fig. 5A ). To characterize the enzymatic 26
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activity, we prepared a peptide array presenting the 15-mer peptide substrates, 1 glycoprotein 1b alpha polypeptide (GP1BA) (19), coagulation factor VIII (CF-8) (20), 2 cholecystokinin (CCK) (21), FSH receptor (FSHR), TSHR (15) and P-selectin 3 glycoprotein ligand-1 (PSGL1) (22) , that are known acceptors for tyrosine sulfation, and 4 detects the incorporation of 35 S-labeled sulfate into the substrates. TPST1, TPST2 and 5 TPST2 (H266Q) expression vectors were transfected into HEK293T. Immunoblot 6 analysis indicated that each protein was expressed at similar level in the transfected cells 7 (Fig. 5B ). Although HEK293T cell expressed both human isozymes, which were detected 8 by RT-PCR, there was no detectable sulfation of all peptide substrates when lysates of 9 mock transfected cell were used (Fig. 5C ). Thus, the basal TPST activity was 10 undetectable level for this assay. Fig. 5C shows that all peptides were sulfated by 11 wild-type TPST2. In contrast, the enzyme activity of mutant TPST2 (H266Q) was 12 reduced to undetectable levels, although the same amount of protein was present on each 13 reaction. Thus, histidine 266 must be a critical residue for TPST activity. We investigated 14 the subcellular distribution of normal and mutant TPST2 tagged with FLAG and the 15 effects of mutant TPST2 on the survival of transfected cells, no changes were found (data 16 not shown). This mutation might affect the affinity of TPST protein for acceptor 17 proteins/PAPS or the enzymatic activity itself. Further mutagenesis and crystallographic 18 studies will be needed to address this issue. 19
20
The tyrosine sulfation of TSHR by TPST2 is crucial for TSH signaling 21
22
In mammals, tyrosine sulfation of proteins is catalyzed by two isozymes; 23 TPST1 and 2. A question arose as to whether the isozyme, TPST1, compensates for a 24 deficiency of TPST2, since the mouse TPST1 has 65% homology with TPST2 at the 25 amino acid level. Previously, Northern analyses indicated that both Tpsts were 26
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ubiquitously expressed in various tissues and cell lines (23, 24) . However, it has not been 1 determined whether the two TPSTs are co-expressed on cells or tissues. To evaluate tissue 2 expression preferences of Tpst isoforms, we examined the expression of the Tpst1 and 3
Tpst2 genes in various mouse tissues, the rat thyrocyte cell line FRTL-5 (Fig. 6A) , murine 4 primary fibroblasts, NIH3T3 cells (data not shown). Semiquantitative RT-PCR analysis 5 was performed concomitantly for both genes in the same tube on each sample, and 6 revealed that the Tpst isoforms co-expressed in the same tissues and cells including 7 thyrocytes, although there are some differences in tissue preference. Further, analyses showed that the grt mutation did not affect steady-state transcription of Tpst1 or 9
Tpst2 itself in any tissues (data not shown). 10
In vitro studies using synthetic peptide acceptors indicated that the two TPST 11 isoforms differed in substrate preference (24, 25) . Inactivation of murine Tpst1 did not 12 result in any abnormality of the thyroid (26). Therefore, we investigated the substrate 13 specificity of TPSTs. As shown in Fig. 5C and D, TPST1 and 2 similarly sulfated GP1BA, 14 CF-8, CCK and PSGL1. In contrast, the preference of TPST2 was 5-fold that of TPST1 15 for TSHR peptides, implying that TPST1 cannot compensate for the deficiency of TPST2 16 activity. 17
In the thyroid, the TSH-bound TSHR induces coupling of the receptor to the G 18 protein and produces intracellular cAMP through the activation of adenylate cyclase (27) . 19
The thyroid gland of the grt mutant exhibited a markedly diminished response of TSH 20 both in vitro and in vivo, although cAMP production was increased following stimulation 21 of the thyroid glands with nonspecific adenylate cyclase activators such as forskolin (12, 22 13) . To obtain further evidence, we performed an in vitro TSH signaling assay with 23 primary fibroblasts obtained from grt/grt mutants. The Lentiviruses encoding Tpst1, 24
Tspt2 and mutant Tpst2 (H266Q) with TSHR cDNA were introduced into grt/grt 25 fibroblasts, and TSH-induced production of cAMP was determined. The grt/grt 26 Sasaki N et al.
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fibroblasts showed an increase in cAMP production when cultured in the presence of 1 forskolin. Stimulation of cells expressing just TSHR (mock) with TSH resulted in a slight 2 increase in cAMP accumulation (Fig. 6B) . The TSH-dependent cAMP accumulation in 3 the cells expressing TPST1 or mutant TPST2 was very low or similar to that of 4 mock-transfected cells. In contrast, in cells expressing TPST2, cAMP accumulation was 5 approximately 2-3 folds higher than that in cells expressing the others. These results 6 strongly suggest that only TPST2 can efficiently mediate the TSH-TSHR signal 7 transduction pathway, whereas TPST1 and TPST2 (H266Q) cannot. Tshr mutant mice, spontaneous and targeted mutants, have been reported (16, 17) . Both 22 mutants can produce thyroglobulin, however, they show reduced iodine uptake in the 23 thyroid. Similarly, the uptake of iodine is markedly lower in grt mice (18). Combining 24 these observations with our data, we propose that sulfation of tyrosine 385 of TSHR by 25 TPST2 is indispensable for the activation of TSH signaling. Since grt/grt mice are unable 26
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to fully respond to TSH, they develop hypothyroidism and dwarfism. The growth of 1 grt/grt mice is virtually normal until 2 wk after birth, then is suppressed in the pubertal 2 period; however, it gradually catch up with those of normal mice after approximately one 3 year. This might be because normal rodent chows provide enough thyroid hormone for 4 survival. 5
Recently, it has been reported that Tpst2 (-/-) mice on the 129/Sv background 6 were produced by gene targeting (28). Tpst2 (-/-) mice showed growth retardation at 4-5 7 wk of age in both sexes, which resembled that in the grt mutants. However, their report 8 could not defined the molecular mechanism of the growth retardation. In our report, we 9 determined Tpst2 as the gene responsible for the severe thyroid dysgenesis, which relates 10 to TSH hyporesponsiveness through positional cloning and transgenic rescue. 11
Furthermore, we show that TPST2 has high degree of substrate specificity for TSHR, and 12 is essential for TSH-TSHR signaling. Therefore, our report has clarified the crucial role 13 of TPST2 for a particular signaling pathway in vivo for the first time. The maximum 14 difference in body weight of Tpst2 (-/-) mice at 5 wk was 20% less compared with normal 15
littermates. In contrast, DW/J-grt mice lost up to 50%. It has been reported that thyroid 16 dysgenesis were displayed in C57BL/6 mice with Pax8 (+/-)/Ttf1 (+/-) and not in 129Sv 17 strain (29). Therefore, Tpst2 (-/-) in the 129 background might be resistant to thyroid 18 dysgenesis. These might represent a spectrum of different degrees of severity of the same 19 underlying molecular defect. In human, most cases of thyroid dysgenesis are sporadic, 20 most patients do not display a clear Mendelian transmission, suggesting the existence of 21 several genetic factors which could contribute to the disorder (30). Therefore, this strain 22 differences should help us to identify modifier gene(s) involved in morphogenesis, 23 growth, and differentiation of the thyroid. The other explanation of phenotypic 24 differences between Tpst2-null mutants and grt mice could be through the dimerization of 25 TPST proteins, because the many sulfotransferases are homo-and/or heterodimer in 26
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solution (31). The physiological significance of dimerization of cytosolic 1 sulfotransferases is not yet clearly defined. However, it has been reported that both 2 TPST1 and TPST2 form homodimer (23, 32). Therefore, if dimerization is essential for 3 the TPST activity, high expression of TPST2 H266Q mutant may result in a significant 4 decrease in TPST1 activity in a dominant-negative manner. This hypothesis is consistent 5 with the result that the dwarfism of grt mice is more severe than that of Tpst2-null mice. 6
Hypothyroidism in human is associated with a marked delay in sexual 7 maturation and development (33). The grt males also demonstrate the severe decrease in 8 testicular weight and the numbers of Leydig cells until 5-8 wk age, whereas they 9 gradually acquire normal structure and function of the testis, finally become fertile at 3-4 10 months (our unpublished data). Thus, we could cross F1 females with grt males to obtain 11 backcrossed progenies. Tpst2 (-/-) mutant males are infertile at 10 wk of age, although 12 spermatogenesis and mating are normal (28). This result is in agreement with previous 13
reports showing a decrease in sperm motility in rats with hypothyroidism (34, 35). 14 However, it has not been described whether Tpst2 (-/-) males become fertile after 10 wk 15 or are infertile throughout their life. If Tpst2 knockout is a phenocopy of the grt mutant, 16 male infertility can be due to dwarfism/hypothyroidism and may also gradually acquire 17 fertility after 10 wk of age. and hormones. In some of these proteins, tyrosine sulfation has been shown to be required 23 for optimal binding, but in many, a functional role of tyrosine sulfation still has been 24 unclear. Thus, although many proteins are possible to be the substrates of TPST2, our 25 current study mainly focuses on TSHR. However, the possibility that the grt phenotype 26
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reflects a defect in other proteins as the substrate of TPST2 in downstream of the TSHR 1 could not be excluded. Tyrosine sulfation might also affect enzymatic activity, protein 2 transportation, localization and lifespan, possibly being important for hemostasis, 3 chemotaxis, inflammation, and development, as well as for viral and cancer pathogenesis 4 (38). 5
In the past several decades, the causative genes of inherited hypothyroidism 6 have been identified in humans and rodents. These genes encode transcription factors, 7 hormones, and their receptors. The post-translational processing in the thyroid has been 8 considered to have a significant role in their correct function. However, these processes 9
have not been shown to be mainly involved in the pathogenesis of thyroid until our 10 reports. Although a mutation of TPST has not been found in human disease, our data 11 suggest that TPST2 may be one of the causative genes for thyroid dysgenesis of unknown 12 were generated by pronuclear injection of the linear transgene into fertilized zygotes 19 prepared from BDF1 mice. RT-PCR analysis of transgene expression in various tissues 20 was performed using primer pair: A/B, tctgactgaccgcgttact/ggccgcatcctccgtgggtt. (Fig.  21   3A) . The transgenic hemizygotes on grt/+ were mated to generate the transgenic grt/grt 22 homozygotes. The following primer pair was used for genotyping transgenic animals: 23 primers C/D, cacactcaagtcatccgtcta/cttgcacgtgtatacagctg (Fig. 3A) , which cannot amplify 24 Sasaki N et al. 14/27 endogenous Tpst2 locus due to the long distance between both primers. For genotyping 1 Tpst2 alleles, PCR and subsequent RFLP analysis using EcoNI have been used. 2 3
Hormonal analysis 4
To test thyroid function of grt/grt mice with or without transgenes, blood was collected 5 into tubes containing 1 mg/ml EDTA at the final concentration and kept on ice, and 6 plasma was obtained by centrifugation. Serum was removed after centrifugation and 7 stored at -20°C until analysis. Serum levels of free T3 and T4 were measured using 8 ACTIVE Free T3 or T4 EIA kits (Diagnostic System lab). Serum TSH was determined 9 using RAT TSH ELISA kit (Shibayagi) according to the manufacturer's instructions with 10 minor modification to optimize the signal intensity. Serum samples from grt mice needed 11 to be diluted 10 times with PBS (pH 7.4). NIDDK-rat TSH RP-3 was used as the 12 standard. 13 14 mRNA detection methods 15
For detecting mutations, total RNA from WT and grt tissues were extracted with TRizol 16 and reverse-transcribed with a RT-PCR kit according to the manufacturer's instructions 17 (Invitrogen). For the quantitation of thyroid-specific gene, each mRNA level of murine 18
Tshr, Nis, Tpo, Tgn and Pax8 was determined using specific primers as follows: 19
Tshr-F/R: acctctcttacccgagccactgc/tccaggcgcatggcgaaggtgat, 20
Nis-F/R: cattcccggatcaacctgatggact/tttagagatgaaaaccagcttccg, 21
Tgn-F/R: cagaccgtagtggggctgatgtg/gcatagtcgtctgtggagtgct, 22
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Tpo-F/R: attgggaagcagatgaaggctct/gggtgtgtcagatctgcacact, 1
Pax8-F/R: gaatattctggcaatgcctacag/tgtacaccctcagactcatctc, 2
Actb-F/R: tgatggtgggaatgggtcag/gaaggctggaaaagagcctc. 3
For the quantitation of mRNA for Tpst1 and Tpst2, RT-PCR was performed for both 4 genes in the same tube on each sample concomitantly. Primers were designed so that the 5 sense primer was shared for amplification of both Tpst1 and Tpst2 genes. The primers 6 used were: tcacggccatgtcttgtaag (Tpst1 antisense); gtgctgttctggttcacctg (Tpst2 antisense) 7 and tgcaggccttcattctggaggtgat (common sense). To determine the optimum PCR 8 amplification conditions in the linear range, three amounts of cDNA (10, 50 and 100 ng) 9
were tested for each sample. Each reaction tube contained 2 µl of 10 × Ex Taq buffer 10 (Takara), 2 µl of 2.5 mM dNTP mixture, 0.1 µl of Ex Taq polymerase (Takara), 1 µl (4 11 µM) of each antisense primer and 2 µl (4 µM) of common sense primer. The total reaction 12 volume was 20 µl. PCR consisted of denaturation at 94°C for 3 min, 25 cycles of 13 denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec and extension at 72°C for 30 14 sec and a final extension at 72°C for 5 min. The PCR products were electrophoresed on 15 1.5% agarose gel. All assays were performed in duplicate. pTriEx1.1-Tpst1-FL, Tpst2-FL, and mutant Tpst2-FL plasmids were transfected into 1 × 26 7 HEK293T cells using Lipofectamine 2000 (Invitrogen). After 48 h, each cell was 1 homogenized in 500 µl of ice-cold 10 mM Tris-HCl (pH 7.5) containing 100 mM NaCl, 1 2 mM EDTA, 1% TritonX-100, 0.1 mM phenylmethylsulfonyl fluoride, 1 mg/ml pepstatin, 3 2 mg/ml aprotinin and 2 mg/ml leupeputin. Expression of each TPST protein in cell 4 lysates (20 µg) was detected by Western blot analysis using a FLAG antibody (Sigma). 5 TPST activity was determined by measuring the transfer of 35 S-sulfate from 35 S-PAPS to 6
Fmoc-based membrane-immobilized 15-mer peptides (39). Peptide arrays, 35 S-PAPS and 7 50 ml of TPST lysate were accomplished by incubating 50 µl of the buffer {50 mM 8 piperazine-1,4-bis(2-ethanesulfonic acid), pH 6.9, 0.4 mM EDTA, 1 mM Mg-acetate, 200 9 mM NaCl, 1 mg/ml BSA, 10 mM dithiothreitol} for 1 h at 37°C. After incubation, peptide 10 arrays were washed with 0.1 M Tris-HCl (pH 8.0) twice. The relative amounts of 11 incorporated radioactivity were visualized and quantified with a BAS2500 Bio-Imaging 12 analyzer (Fuji Film). All assays were performed in duplicate. 
